logo
Login

GLOBAL HEALTH LIMITED (MEDANTA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transpla…

MEDANTAUpdated 29 Aug 2026, 2:35

Global Health Limited

Market Cap

₹39,486Cr.

Current Price

₹1,472

High / Low

₹1,544/955

Stock P/E

79.5

ROE13.2%
ROCE16.4%
Book Value₹149
Face Value₹2.00
Dividend Yield0.03%

About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days31414237393632263338
Inventory Days36262637393334292423
Days Payable13212414213513484113848193
Cash Conversion Cycle-66-56-74-61-56-16-48-29-24-32
Working Capital Days-31-16-7-11-20-6-27-24-14-4
ROCE %—6%8%11%7%17%16%23%20%16%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:35

Designed & Shipped by Harshit Bansal